Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 50,000 shares at $50.37 ($2.6M) on 2020-11-16, disclosed to the SEC on 2020-11-16.
Open-market sale of $2.6M FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.37 | 4,932 | $248K | 9.6% |
| 2 | $50.37 | 4,932 | $248K | 9.6% |
| 3 | $51.60 | 5,287 | $273K | 10.5% |
| 4 | $51.60 | 5,287 | $273K | 10.5% |
| 5 | $52.40 | 14,781 | $775K | 29.9% |
| 6 | $52.40 | 14,781 |
| $775K |
| 29.9% |
| Total | $51.83 avg | 50,000 | $2.6M | 100% |
| Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |
| FATE | SELL | 2020-01-02 | $973K | — | Filing → |